OncoSec Medical (OTCBB:ONCS), which is developing its advanced-stage electro-oncology therapies to treat solid tumor cancers, announced today that its president and CEO, Punit Dhillon, will be presenting a corporate overview at two upcoming investor conferences.
The first is the Rodman & Renshaw Global Healthcare Conference in New York City, to be held from September 11 to 13 at the The Waldorf Astoria. OncoSec's presentation is scheduled for September 12 at 3:40pm ET, with a live and archived webcast to be accessible on the company's website at www.oncosec.com.
The second event will be the ProActive Investors Investor Forum in New York City on September 15, at the Intercontinental New York Barclay Hotel. OncoSec will be presenting at 6:00pm ET.
OncoSec's therapies, currently in phase two trials, combine its proprietary electroporation delivery technology with a chemotherapeutic or DNA-based immunotherapeutics. Targeted local delivery of these agents is designed to selectively destroy cancerous tumors while sparing healthy normal tissue, resulting in improved outcomes.
Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.
No comments:
Post a Comment